Literature DB >> 34086059

Digital health solutions in the screening of subclinical atrial fibrillation.

Sebastian König1,2, Andreas Bollmann3,4, Gerhard Hindricks3,4.   

Abstract

Atrial fibrillation (AF) will become one of the biggest challenges in cardiovascular medicine in the near future. Attempting an improvement in future patient care calls explicitly for the screening of subclinical AF. Digital health solutions implementing communication technologies for the collection and analysis of digitally assessable data will most likely serve this need. Several new rapidly developing methods were introduced in the past decade. Although the vast majority still require scientific validation, the body of evidence is growing and several randomized controlled trials are planned. This review aims to give an overview of current technologies with a specific focus on mobile health (mHealth) and appraise their value with regard to the available scientific data.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Mobile health; Outpatient management; Screening and prevention; Telemedicine; Wearables

Year:  2021        PMID: 34086059     DOI: 10.1007/s00059-021-05041-2

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  60 in total

1.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

2.  Prevalence and predictors of atrial fibrillation in patients with embolic stroke of undetermined source: a real-life single-center retrospective study.

Authors:  Fabio Melis; Marilena Guido; Claudia Amellone; Marco Suppo; Maria Bonanno; Consuelo Bovio; Andrea Pessia; Katia Savio; Maria Teresa Lucciola; Elisa Ebrille; Giulia Guastamacchia; Daniela Cassano; Paola Filippi; Eva Milano; Massimo Giammaria; Daniele Imperiale
Journal:  Neurol Sci       Date:  2021-01-14       Impact factor: 3.307

3.  A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.

Authors:  Tatjana S Potpara; Marija M Polovina; Jelena M Marinkovic; Gregory Y H Lip
Journal:  Int J Cardiol       Date:  2013-08-01       Impact factor: 4.164

4.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

Authors:  Bouwe P Krijthe; Anton Kunst; Emelia J Benjamin; Gregory Y H Lip; Oscar H Franco; Albert Hofman; Jacqueline C M Witteman; Bruno H Stricker; Jan Heeringa
Journal:  Eur Heart J       Date:  2013-07-30       Impact factor: 29.983

5.  Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: Characteristics and prognostic implications.

Authors:  Konstantinos C Siontis; Bernard J Gersh; Jill M Killian; Peter A Noseworthy; Pamela McCabe; Susan A Weston; Veronique L Roger; Alanna M Chamberlain
Journal:  Heart Rhythm       Date:  2016-03-04       Impact factor: 6.343

6.  Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.

Authors:  Giuseppe Boriani; Cecile Laroche; Igor Diemberger; Elisa Fantecchi; Mircea Ioachim Popescu; Lars Hvilsted Rasmussen; Gianfranco Sinagra; Lucian Petrescu; Luigi Tavazzi; Aldo P Maggioni; Gregory Y H Lip
Journal:  Am J Med       Date:  2014-12-20       Impact factor: 4.965

7.  Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).

Authors:  Munveer Thind; DaJuanicia N Holmes; Marwan Badri; Karen S Pieper; Amitoj Singh; Rosalia G Blanco; Benjamin A Steinberg; Gregg C Fonarow; Bernard J Gersh; Kenneth W Mahaffey; Eric D Peterson; James A Reiffel; Jonathan P Piccini; Peter R Kowey
Journal:  Am J Cardiol       Date:  2018-08-20       Impact factor: 2.778

8.  Prevalence of Atrial Fibrillation Subtypes in Italy and Projections to 2060 for Italy and Europe.

Authors:  Antonio Di Carlo; Augusto Zaninelli; Fabio Mori; Domenico Consoli; Leonardo Bellino; Marzia Baldereschi; Bruno Sgherzi; Chiara Gradia; Maria Grazia DʼAlfonso; Alessandro Cattarinussi; Giovanni Pracucci; Benedetta Piccardi; Bianca Maria Polizzi; Domenico Inzitari
Journal:  J Am Geriatr Soc       Date:  2020-08-12       Impact factor: 5.562

9.  Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study.

Authors:  Steven A Lubitz; Xiaoyan Yin; David D McManus; Lu-Chen Weng; Hugo J Aparicio; Allan J Walkey; Jose Rafael Romero; Carlos S Kase; Patrick T Ellinor; Philip A Wolf; Sudha Seshadri; Emelia J Benjamin
Journal:  Stroke       Date:  2017-01-12       Impact factor: 7.914

10.  Stroke as the First Manifestation of Atrial Fibrillation.

Authors:  Jussi Jaakkola; Pirjo Mustonen; Tuomas Kiviniemi; Juha E K Hartikainen; Antti Palomäki; Päivi Hartikainen; Ilpo Nuotio; Antti Ylitalo; K E Juhani Airaksinen
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.